Ameeta Kelekar
- Molecular Biology top 5%
- Epidemiology top 5%
- Immunology top 5%
- Oncology top 5%
- Cancer Research top 5%
- Co-authors
- Craig B. ThompsonMichael D. ColeMaura McDonnellMd. Joynal AbedinUte LehmannIndira V. SubramanianJohn E. HarlanBrian S. Chang
- Topics
- Cell death mechanisms and regulation (13 papers)Autophagy in Disease and Therapy (8 papers)Cancer-related Molecular Pathways (6 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Ameeta Kelekar
43 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 2.3k
- Epidemiology 864
- Immunology 632
- Oncology 564
- Cancer Research 514
Countries citing papers authored by Ameeta Kelekar
This map shows the geographic impact of Ameeta Kelekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ameeta Kelekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ameeta Kelekar more than expected).
Fields of papers citing papers by Ameeta Kelekar
This network shows the impact of papers produced by Ameeta Kelekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ameeta Kelekar. The network helps show where Ameeta Kelekar may publish in the future.
Co-authorship network of co-authors of Ameeta Kelekar
This figure shows the co-authorship network connecting the top 25 collaborators of Ameeta Kelekar. A scholar is included among the top collaborators of Ameeta Kelekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ameeta Kelekar. Ameeta Kelekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 193 | |
| 3 | 81 | |
| 4 | 24 | |
| 5 | EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection | 1 |
| 6 | 107 | |
| 7 | 33 | |
| 8 | 7 | |
| 9 | 13 | |
| 10 | 90 | |
| 11 | 90 | |
| 12 | 21 | |
| 13 | 84 | |
| 14 | 426 | |
| 15 | 124 | |
| 16 | 2 | |
| 17 | 179 | |
| 18 | 94 | |
| 19 | 120 | |
| 20 | 7 |
About Ameeta Kelekar
Ameeta Kelekar is a scholar working on Biological Psychiatry, Cancer Research and Oncology, having authored 43 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (13 papers), Autophagy in Disease and Therapy (8 papers) and Cancer-related Molecular Pathways (6 papers). The work is most often cited by research in Physiology (207 citations), Cancer Research (514 citations) and Molecular Biology (2.3k citations). Ameeta Kelekar has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Craig B. Thompson, Michael D. Cole, Maura McDonnell, Md. Joynal Abedin, Ute Lehmann, Indira V. Subramanian, John E. Harlan, Brian S. Chang, Stephen W. Fesik and Sundaram Ramakrishnan. Their work appears in journals such as Nature, Cell and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.